Q: What is a branded GLP-1 medication
Pajares, M
For most patients, symptoms improve over time as the body adapts to the medication, though some individuals may experience persistent symptoms requiring ongoing management or dose adjustment
DOI: Published online: February 24, 2021 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Corresponding author: Young Min Cho
These findings indicate that MC3R activity may play an important role in producing tolerable and clinically meaningful weight loss in a more diverse patient population
Nicholls SJ, Bhatt DL, Buse JB, Prato SD, Kahn SE, Lincoff AM, McGuire DK, Nauck MA, Nissen SE, Sattar N, Zinman B, Zoungas S, Basile J, Bartee A, Miller D, Nishiyama H, Pavo I, Weerakkody G, Wiese RJ, DAlessio D